Experience

Zomedica

• United States
• Veterinary
• 1 - 100 Employee

• Chief Operating Officer

  • Dec 2021 - Present



BGA Manufacturing LLC

• Columbus, Ohio Area

• Principal Owner

  • Sep 2001 - Present

  Manufacturing and Organizational Consulting Manufacturing and Organizational Consulting



Cardiox Corporation

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Sr. Vice President & Chief Operating Officer

  • Jul 2012 - Nov 2015

  Cardiox an early stage medical device and technology company. Cardiox an early stage medical device and technology company.



Mammotome

• United States
• Medical Equipment Manufacturing
• 300 - 400 Employee

• VP of Manufacturing

  • Aug 2011 - Jul 2012

  Devicor, revenue of 160 million, the parent corporation of Mammotome, is a fast-growing global company dedicated to acquiring and growing healthcare companies. With an initial focus on the breast cancer market, the company is dedicated to building a global business through the investment in, and development of, tools and technologies that facilitate minimally invasive medical procedures. Devicor, revenue of 160 million, the parent corporation of Mammotome, is a fast-growing global company dedicated to acquiring and growing healthcare companies. With an initial focus on the breast cancer market, the company is dedicated to building a global business through the investment in, and development of, tools and technologies that facilitate minimally invasive medical procedures.



Neoprobe Corporation

• Medical Device
• 1 - 100 Employee

• VP of Manufacturing Operations

  • Jun 2004 - Aug 2011

  Neoprobe sold its device assets to Devicor who previously provided distribution and marketing services to Neoprobe for the Gamma Detection System portfolio. Financial terms of the agreement included $30 million cash at close plus up to an additional $20 million in royalties based on revenue milestones. Neoprobe sold its device assets to Devicor who previously provided distribution and marketing services to Neoprobe for the Gamma Detection System portfolio. Financial terms of the agreement included $30 million cash at close plus up to an additional $20 million in royalties based on revenue milestones.



Enpath Medical

• Medical Equipment Manufacturing
• 1 - 100 Employee

• VP of Manufacturing

  • Feb 2002 - Jun 2004

  VP of Manufacturing of Biomec Cardiovascular (BCI), a developer of implantable neuromodulation and CRDM leads and delivery systems. BCI was acquired by Enpath Medical (Nasdaq: NPTH) in October 2003 for $24 million in cash and stock. Total capital invested in BCI from inception was $5.5 million. VP of Manufacturing of Biomec Cardiovascular (BCI), a developer of implantable neuromodulation and CRDM leads and delivery systems. BCI was acquired by Enpath Medical (Nasdaq: NPTH) in October 2003 for $24 million in cash and stock. Total capital invested in BCI from inception was $5.5 million.



Astro Instrumentation

• Strongsville Ohio

• Director of Manufacturing Operations

  • 1998 - Feb 2002



Bayer Diagnostics

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Operations Manager

  • 1989 - 1998



Bailey Controls

• Wickliffe, Ohio

• Senior Buyer Planner

  • 1985 - 1989



Fisher Body - GM

• Euclid, Ohio

• Foreman

  • 1983 - 1985